Genpharmasec Ltd
GENPHARMABSE
₹1.02▼ -0.05 (-4.67%)
Whole company worth₹56 Cr
ProfitLoss-making
1-year range₹1 – ₹2
The short version
A fast-growing, thinly profitable business — priced in line with what it earns.
Everything below is worked out from Genpharmasec's own filed results and the exchange's data, and written so you do not need to know any finance terms. Where a term matters, we say what it means.
01What does it do?
Genpharmasec is a micro-sized company in trading & distributors.
Incorporated in 1992, Generic Pharmasec Ltd deals in pharmaceutical activities /services and trades in equity shares
- Whole company is worth
- ₹56 crore
- Run by
- Sohan Chaturvedi
- Employees
- 10
- Shareholders
- 99,856 people
- Listed since
- 1996
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales have grown 75% a year for 3 years.
At that pace a business doubles in size roughly every 1 year. Profit, though, fell 18% a year over the same stretch.
Point at a bar for exact figures · amounts in ₹ crore
03Does it make money?
Out of every ₹100 it sells, it keeps ₹0.4 as profit.
Here is where the money from Genpharmasec's sales went in FY26, the latest full year it has reported.
₹92
- ₹92Making or buying what it sellsraw materials, stock, goods bought for resale
- ₹5.0Running the businessstaff, rent, marketing, power and everything else
- ₹0.9Interest on its loansthe cost of borrowed money
- ₹1.6Wear and tearmachines, stores and buildings losing value over time
- ₹0.3Taxincome tax paid to the government
- ₹0.4Profit it keepswhat is left for the company's owners
On the money its owners have put in
It earns ₹2 a year on every ₹100 its owners have invested.
Bank FD ~₹6–7
₹2
₹-10₹0₹10₹20₹30₹40
That figure is called return on equity (ROE). Under ₹12 is a thin return for the risk of owning shares. For comparison, a bank fixed deposit pays roughly ₹6–7.
Does the profit turn into cash?
For every ₹100 of profit it reported, ₹-1125 actually came in as cash.
Profit it reported₹1.6 Cr
Cash its business brought in−₹18 Cr
Over the last 3 years: ₹1.6 crore of profit but only −₹18 crore of cash. A wide gap like this is worth understanding before trusting the profit figure.
04Is the price high or low?
Genpharmasec made a loss, so there is no "price for profit" to measure.
Investors are paying for what they hope it will earn later, not what it earns today. That makes the price harder to judge and more sensitive to news.
The share price over the past year
It is 37% below its highest price of the past year and 36% above its lowest.
05Who owns it?
Its founders and parent group own 32 of every 100 shares — a large stake, though not a majority.
If the company were split into 100 equal shares, this is who would hold them. Last quarter, founders & parent group raised their stake by 2.1 percentage points. 99,856 people and institutions hold its shares.
As filed for the quarter ending 30 Sept 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
Two things going well, two things worth watching.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
- Sales have compounded at 75% a year.
- Founders raised their stake by 2.1 points last quarter.
Worth watching
- Thinly traded — only about ₹4 lakh of shares change hands a day, so buying or selling can move the price.
- The share price is 37% below its high of the past year.
07What happened lately?
Latest quarter: sales up 313%, a loss.
Apr–Jun 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹50 Cr
▲ 312.9% on a year earlier
Loss
₹0.2 Cr
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Genpharmasec?
This page describes Genpharmasec using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Genpharmasec Ltd (GENPHARMA): company summary
The company's business has grown significantly, with annual revenue rising 315.0% to ₹140 crore.
Genpharmasec Ltd (GENPHARMA) is a micro-cap Commercial Services company valued at ₹56 crore operating in Trading & Distributors on the NSE and BSE.
- Recent price move
- Genpharmasec Ltd last traded at ₹1.02, down 4.67% on the day.
- Recent developments
- On 2026-09-30, promoter holding increased by 2.08 percentage points to 32.06%. In the latest quarter, the company reported a net profit loss of ₹0 crore, compared to a net profit of ₹1 crore in the same quarter a year earlier.
- Financial performance
- The company's business has grown significantly, with annual revenue rising 315.0% to ₹140 crore. However, net profit fell 54.5% year-on-year to ₹1 crore, and the net profit margin dropped 3.3 percentage points to 0.4%. The latest quarter saw revenue surge 312.9% to ₹50 crore, but net profit swung to a loss of ₹0 crore from a profit of ₹1 crore in the same quarter a year earlier.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here; the stock trades at 0.97 times book value.
- Things to watch
- The company's net profit margin has fallen sharply to 0.4%, down 3.3 percentage points from the prior year. The latest quarter showed a net profit loss of ₹0 crore, reversing a profit of ₹1 crore in the same quarter a year earlier. The stock is 34.0% below its 52-week high.
- Where it stands
- The company's revenue has grown rapidly, with annual revenue up 315.0% to ₹140 crore, but net profit fell 54.5% to ₹1 crore. The latest quarter saw a net profit loss of ₹0 crore, compared to a profit of ₹1 crore in the same quarter a year earlier. The stock is 34.0% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Commercial Services stocks · Trading & Distributors
Explore Genpharmasec Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Genpharmasec Ltd peers in Commercial Services
Other Commercial Services stocks on the NSE & BSE. See the full Commercial Services sector list.
Related tools & concepts
Value Genpharmasec Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing